Verhasselt, Peter
Johnson & Johnson (United Kingdom) · Janssen Research & Development (United States)
3 papers on CoChat
Most cited papers
- Verified
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science
Tuberculosis Research and EpidemiologyATP Synthase and ATPases Research
Cited by 2,191
- Verified
Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans
Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 382
- Verified
Cloning and characterization of human histone deacetylase 8
Van den Wyngaert, I., de Vries, W., Kremer, A., Neefs, J.-M., Verhasselt, P., Luyten, W. H. M. L., & Kass, S. U. (2000) · FEBS Letters
Histone Deacetylase Inhibitors ResearchGenomics and Chromatin Dynamics
Cited by 143
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free